Benoxinate Hydrochloride — Active Pharmaceutical Ingredient

Benoxinate Hydrochloride is an active pharmaceutical ingredient found in 3 FDA-approved drug products. Forms: SOLUTION/DROPS. Routes: OPHTHALMIC.

This content is for informational purposes only. Always consult a healthcare professional.

Benoxinate Hydrochloride (3 brand names, 1 dosage form, 1 route)

Available dosage forms: SOLUTION/DROPS.

Routes of administration: OPHTHALMIC.

Brand Names

  • ALTAFLUOR BENOX
  • BENOXINATE HYDROCHLORIDE
  • FLUORESCEIN SODIUM AND BENOXINATE HYDROCHLORIDE

Indications and Usage

Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is indicated for ophthalmic procedures in adult and pediatric patients requiring a disclosing agent in combination with a topical ophthalmic anesthetic agent.

Dosage and Administration

Instill 1 to 2 drops topically in the eye as needed.

Contraindications

Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4% is contraindicated in patients with known hypersensitivity to any component of this product.

Adverse Reactions

The following serious ocular adverse reactions are described elsewhere in the labeling: Corneal Toxicity [see Warnings and Precautions (5.1)] Corneal Injury Due to Insensitivity [see Warnings and Precautions (5.2)] The following adverse reactions have been identified following use of Fluorescein Sodium and Benoxinate Hydrochloride Ophthalmic Solution, 0.3%/0.4%: ocular hyperemia, burning, stinging, eye irritation, blurred vision and punctate keratitis. Because these reactions are reported voluntarily from a population of uncertain size, it is not always possible to reliably estimate their frequency or establish a causal relationship to drug exposure.

⚠ Caution
Medical Disclaimer: This information is for educational purposes only. Always consult a healthcare professional before taking any medication.